Cargando…
Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children
In the last two decades, improvement on asthma treatment has been merely marginal for both adults and children; inhaled corticosteroids (ICS) combined with β-2-mimetics remain the main therapy [3,4]. “New” therapies are just variations on ICS or, for children, on various other drugs that were allowe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
King Faisal Specialist Hospital and Research Centre
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152565/ https://www.ncbi.nlm.nih.gov/pubmed/35663792 http://dx.doi.org/10.1016/j.ijpam.2021.02.002 |